New distributor agreement in the UK
17 november, 2021
AroCell continues to work with expansion to other markets with new distributors. Today, the company has signed a distributor agreement with Rock Medical Ltd covering the UK and Northern Ireland for the sale of UBC® Rapid.
Rock Medical is a UK based limited company founded in 2020 and working with supply chain solutions in the medical device industry, with a focus on the urology market. Rock Medical collaborates with several private health clinics around the UK, as well as major facilities such as The London Clinic and Genesis care.
UBC® Rapid is a rapid test intended for the detection of bladder cancer, especially in high-risk patients, and for monitoring the development of the disease after an established diagnosis. This test is clinically documented and is already used today in routine healthcare, including in Germany.
“We look forward to this new partnership with Rock Medical for distribution and marketing of UBC® Rapid," said Anders Hultman, CEO of AroCell. "This supports our commercialization strategy of expanding into new markets. With the agreement, we expect increased sales activity in Europe, which is one of our most important markets at the moment.”
Contacts
Anders Hultman, CEOPhone: +46(0)18 50 30 20E-mail: anders.hultman@arocell.com
About AroCell
AroCell AB (publ) is a Swedish company that develops and markets blood and urine sample tests. The corporation specializes in oncology and bacteriology. The company has a broad product portfolio, used in healthcare and established in various markets. In oncology, AroCell uses various biomarkers, TK1 and cytokeratins, to support the treatment of various cancers such as breast, prostate, and bladder cancers. AroCell's product portfolio also includes a rapid bacteriological test for a simple and safe diagnosis of typhoid fever. AroCell (AROC) is listed on Nasdaq First North Growth Market with Redeye AB as Certified Adviser: Certifiedadviser@redeye.se, +46 (0)8 121 576 90. For more information; www.arocell.com
Attachments
New distributor agreement in the UK
Ämnen i artikeln
New distributor agreement in the UK
17 november, 2021
AroCell continues to work with expansion to other markets with new distributors. Today, the company has signed a distributor agreement with Rock Medical Ltd covering the UK and Northern Ireland for the sale of UBC® Rapid.
Rock Medical is a UK based limited company founded in 2020 and working with supply chain solutions in the medical device industry, with a focus on the urology market. Rock Medical collaborates with several private health clinics around the UK, as well as major facilities such as The London Clinic and Genesis care.
UBC® Rapid is a rapid test intended for the detection of bladder cancer, especially in high-risk patients, and for monitoring the development of the disease after an established diagnosis. This test is clinically documented and is already used today in routine healthcare, including in Germany.
“We look forward to this new partnership with Rock Medical for distribution and marketing of UBC® Rapid," said Anders Hultman, CEO of AroCell. "This supports our commercialization strategy of expanding into new markets. With the agreement, we expect increased sales activity in Europe, which is one of our most important markets at the moment.”
Contacts
Anders Hultman, CEOPhone: +46(0)18 50 30 20E-mail: anders.hultman@arocell.com
About AroCell
AroCell AB (publ) is a Swedish company that develops and markets blood and urine sample tests. The corporation specializes in oncology and bacteriology. The company has a broad product portfolio, used in healthcare and established in various markets. In oncology, AroCell uses various biomarkers, TK1 and cytokeratins, to support the treatment of various cancers such as breast, prostate, and bladder cancers. AroCell's product portfolio also includes a rapid bacteriological test for a simple and safe diagnosis of typhoid fever. AroCell (AROC) is listed on Nasdaq First North Growth Market with Redeye AB as Certified Adviser: Certifiedadviser@redeye.se, +46 (0)8 121 576 90. For more information; www.arocell.com
Attachments
New distributor agreement in the UK
Ämnen i artikeln
Rapportperioden
Plejd
Inflationen
-992x558.webp&w=3840&q=75)
Rapportperioden
Plejd
Inflationen
Marknadsöversikt
1 DAG %
Senast
1 mån
Privatekonomi med Placeras expert
Affärsvärlden
